NAZIMUDDIN MOHAMMED: Open Payments
NPI 1316974249 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 22 payments from 12 companies in 2025. Trend: 2023 $3,602 · 2024 $1,117 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $151 |
| ABBVIE INC. | 4 | $97 |
| Teva Pharmaceuticals USA, Inc. | 2 | $60 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Sage Therapeutics, LLC | 1 | $24 |
| Tris Pharma Inc | 1 | $23 |
| Almatica Pharma LLC | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, COBENFY, ZURZUVAE, Onyda XR.
Industry payments across TX — which companies pay providers there.
